C99H114F15N33O12S — CID 157406128
6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-yl-N-pyridin-4-ylpyrimidin-4-amine;N-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]-5-(diethylaminomethyl)-1,3-thiazol-2-amine;tert-butyl 4-[6-[6-amino-4-(trifluoromethyl)-3-pyridinyl]-2-morpholin-4-ylpyrimidin-4-yl]oxypiperidine-1-carboxylate;5-[2-morpholin-4-yl-6-[(3R)-oxolan-3-yl]oxypyrimidin-4-yl]-4-(trifluoromethyl)pyridin-2-amine;5-[2-morpholin-4-yl-6-[(3S)-oxolan-3-yl]oxypyrimidin-4-yl]-4-(trifluoromethyl)pyridin-2-amine (PubChem CID 157406128) has the molecular formula C99H114F15N33O12S and a molecular weight of 2275.26 g/mol. Its IUPAC name is 6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-yl-N-pyridin-4-ylpyrimidin-4-amine;N-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]-5-(diethylaminomethyl)-1,3-thiazol-2-amine;tert-butyl 4-[6-[6-amino-4-(trifluoromethyl)-3-pyridinyl]-2-morpholin-4-ylpyrimidin-4-yl]oxypiperidine-1-carboxylate;5-[2-morpholin-4-yl-6-[(3R)-oxolan-3-yl]oxypyrimidin-4-yl]-4-(trifluoromethyl)pyridin-2-amine;5-[2-morpholin-4-yl-6-[(3S)-oxolan-3-yl]oxypyrimidin-4-yl]-4-(trifluoromethyl)pyridin-2-amine.
| Compound Name | 6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-yl-N-pyridin-4-ylpyrimidin-4-amine;N-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]-5-(diethylaminomethyl)-1,3-thiazol-2-amine;tert-butyl 4-[6-[6-amino-4-(trifluoromethyl)-3-pyridinyl]-2-morpholin-4-ylpyrimidin-4-yl]oxypiperidine-1-carboxylate;5-[2-morpholin-4-yl-6-[(3R)-oxolan-3-yl]oxypyrimidin-4-yl]-4-(trifluoromethyl)pyridin-2-amine;5-[2-morpholin-4-yl-6-[(3S)-oxolan-3-yl]oxypyrimidin-4-yl]-4-(trifluoromethyl)pyridin-2-amine |
|---|---|
| PubChem CID | 157406128 |
| Molecular Formula | C99H114F15N33O12S |
| Molecular Weight | 2275.26 g/mol |
| Exact Mass | 2273.88 |
| IUPAC Name | 6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-yl-N-pyridin-4-ylpyrimidin-4-amine;N-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]-5-(diethylaminomethyl)-1,3-thiazol-2-amine;tert-butyl 4-[6-[6-amino-4-(trifluoromethyl)-3-pyridinyl]-2-morpholin-4-ylpyrimidin-4-yl]oxypiperidine-1-carboxylate;5-[2-morpholin-4-yl-6-[(3R)-oxolan-3-yl]oxypyrimidin-4-yl]-4-(trifluoromethyl)pyridin-2-amine;5-[2-morpholin-4-yl-6-[(3S)-oxolan-3-yl]oxypyrimidin-4-yl]-4-(trifluoromethyl)pyridin-2-amine |
| SMILES | CC(C)(C)OC(=O)N1CCC(Oc2cc(-c3cnc(N)cc3C(F)(F)F)nc(N3CCOCC3)n2)CC1.CCN(CC)Cc1cnc(Nc2cc(-c3cnc(N)nc3C(F)(F)F)nc(N3CCOCC3)n2)s1.Nc1cc(C(F)(F)F)c(-c2cc(O[C@@H]3CCOC3)nc(N3CCOCC3)n2)cn1.Nc1cc(C(F)(F)F)c(-c2cc(O[C@H]3CCOC3)nc(N3CCOCC3)n2)cn1.Nc1ncc(-c2cc(Nc3ccncc3)nc(N3CCOCC3)n2)c(C(F)(F)F)n1 |
| InChI | InChI=1S/C24H31F3N6O4.C21H26F3N9OS.C18H17F3N8O.2C18H20F3N5O3/c1-23(2,3)37-22(34)33-6-4-15(5-7-33)36-20-13-18(30-21(31-20)32-8-10-35-11-9-32)16-14-29-19(28)12-17(16)24(25,26)27;1-3-32(4-2)12-13-10-27-20(35-13)30-16-9-15(28-19(29-16)33-5-7-34-8-6-33)14-11-26-18(25)31-17(14)21(22,23)24;19-18(20,21)15-12(10-24-16(22)28-15)13-9-14(25-11-1-3-23-4-2-11)27-17(26-13)29-5-7-30-8-6-29;2*19-18(20,21)13-7-15(22)23-9-12(13)14-8-16(29-11-1-4-28-10-11)25-17(24-14)26-2-5-27-6-3-26/h12-15H,4-11H2,1-3H3,(H2,28,29);9-11H,3-8,12H2,1-2H3,(H2,25,26,31)(H,27,28,29,30);1-4,9-10H,5-8H2,(H2,22,24,28)(H,23,25,26,27);2*7-9,11H,1-6,10H2,(H2,22,23)/t;;;2*11-/m...10/s1 |
| InChIKey | BNSUJUXNGROGMK-ZPSQBKBWSA-N |
| XLogP | 13.97 |
| TPSA | 540.35 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 45 |
| Rotatable Bonds | 24 |
| Heavy Atoms | 160 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2275.26 |
| LogP ≤ 5 | 13.97 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 45 |